These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 30898647

  • 1. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM, Lian GY, Song Y, Huang YF, Gong Y.
    Life Sci; 2019 Aug 15; 231():116335. PubMed ID: 30898647
    [Abstract] [Full Text] [Related]

  • 2. Overexpressed miR-195 attenuated immune escape of diffuse large B-cell lymphoma by targeting PD-L1.
    He B, Yan F, Wu C.
    Biomed Pharmacother; 2018 Feb 15; 98():95-101. PubMed ID: 29247952
    [Abstract] [Full Text] [Related]

  • 3. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S, Wang K, Huang X, Zhao Z, Zhao Z.
    Int J Immunopathol Pharmacol; 2019 Feb 15; 33():2058738419859699. PubMed ID: 31240979
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LncRNA NEAT1 regulate diffuse large B-cell lymphoma by targeting miR-495-3p/PD-L1 axis.
    Yuan J, Yang J, Wang R, Hao H, Li J.
    Immunopharmacol Immunotoxicol; 2022 Jun 15; 44(3):429-436. PubMed ID: 35352617
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LncRNA HCG18 suppresses CD8+ T cells to confer resistance to cetuximab in colorectal cancer via miR-20b-5p/PD-L1 axis.
    Xu YJ, Zhao JM, Ni XF, Wang W, Hu WW, Wu CP.
    Epigenomics; 2021 Aug 15; 13(16):1281-1297. PubMed ID: 34523356
    [Abstract] [Full Text] [Related]

  • 14. FOXP4-AS1 promotes CD8+ T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1.
    Shen GY, Zhang Y, Huang RZ, Huang ZY, Yang LY, Chen DZ, Yang SB.
    Immunol Res; 2024 Aug 15; 72(4):766-775. PubMed ID: 38687433
    [Abstract] [Full Text] [Related]

  • 15. lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3p.
    Tian Y, Li L, Lin G, Wang Y, Wang L, Zhao Q, Hu Y, Yong H, Wan Y, Zhang Y.
    Leuk Lymphoma; 2021 Jul 15; 62(7):1574-1584. PubMed ID: 33682607
    [Abstract] [Full Text] [Related]

  • 16. CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1.
    Dong L, Huang J, Gao X, Du J, Wang Y, Zhao L.
    Cancer Sci; 2022 Aug 15; 113(8):2888-2903. PubMed ID: 35579082
    [Abstract] [Full Text] [Related]

  • 17. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
    Deng L, Jiang L, Tseng KF, Liu Y, Zhang X, Dong R, Lu Z, Wang X.
    Cancer Biomark; 2018 Aug 15; 23(2):157-164. PubMed ID: 30175971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
    Zhou WY, Zhang MM, Liu C, Kang Y, Wang JO, Yang XH.
    J Cell Physiol; 2019 Dec 15; 234(12):23176-23189. PubMed ID: 31206665
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.